Rainmed Medical Limited (HKG:2297)
Hong Kong · Delayed Price · Currency is HKD 0.2850
+0.0200 (7.55%)
Feb 11, 2026, 4:08 PM HKT
Rainmed Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23.36 | 39.82 | 73.22 | 83.6 | 81.2 | |
Revenue Growth (YoY) | -53.01% | -45.61% | -12.42% | 2.96% | - |
Cost of Revenue | 13.03 | 15.96 | 24.67 | 13.78 | 12.17 |
Gross Profit | 10.33 | 23.87 | 48.55 | 69.82 | 69.03 |
Selling, General & Admin | 80.61 | 97.84 | 145.57 | 176.07 | 185.33 |
Research & Development | 23.34 | 35.44 | 41.33 | 44.17 | 26.97 |
Other Operating Expenses | -3.37 | -9.29 | -6.69 | -5.23 | -0.43 |
Operating Expenses | 100.58 | 124 | 180.21 | 215.01 | 211.87 |
Operating Income | -90.25 | -100.13 | -131.66 | -145.19 | -142.84 |
Interest Expense | -0.92 | -0.94 | -1.31 | -0.76 | -3.86 |
Interest & Investment Income | 1.65 | 3.93 | 12.41 | 3.5 | 1.81 |
Currency Exchange Gain (Loss) | -0.61 | -0.66 | 1.08 | 2.02 | 0.07 |
Other Non Operating Income (Expenses) | - | - | - | -1,211 | -493.87 |
EBT Excluding Unusual Items | -90.13 | -97.79 | -119.48 | -1,351 | -638.68 |
Impairment of Goodwill | -5.78 | -5.78 | - | - | - |
Gain (Loss) on Sale of Investments | 2.93 | 1.25 | 2.4 | 0 | 0.04 |
Gain (Loss) on Sale of Assets | -0.18 | -0.01 | -0.01 | -0.02 | -0.04 |
Asset Writedown | -12.98 | -12.98 | - | - | - |
Pretax Income | -106.14 | -115.3 | -117.09 | -1,351 | -638.69 |
Income Tax Expense | -0.04 | 0.24 | -0.02 | -5.45 | -5.04 |
Earnings From Continuing Operations | -106.11 | -115.54 | -117.07 | -1,346 | -633.65 |
Minority Interest in Earnings | 2.09 | 2.05 | 1.24 | - | 0 |
Net Income | -104.02 | -113.5 | -115.83 | -1,346 | -633.65 |
Net Income to Common | -104.02 | -113.5 | -115.83 | -1,346 | -633.65 |
Shares Outstanding (Basic) | 1,174 | 1,168 | 1,168 | 898 | 643 |
Shares Outstanding (Diluted) | 1,174 | 1,168 | 1,168 | 898 | 643 |
Shares Change (YoY) | 0.55% | - | 30.01% | 39.63% | - |
EPS (Basic) | -0.09 | -0.10 | -0.10 | -1.50 | -0.99 |
EPS (Diluted) | -0.09 | -0.10 | -0.10 | -1.50 | -0.99 |
Free Cash Flow | -128.25 | -128.5 | -208.97 | -128.33 | -103.67 |
Free Cash Flow Per Share | -0.11 | -0.11 | -0.18 | -0.14 | -0.16 |
Gross Margin | 44.22% | 59.93% | 66.31% | 83.52% | 85.02% |
Operating Margin | -386.32% | -251.43% | -179.81% | -173.66% | -175.91% |
Profit Margin | -445.27% | -284.99% | -158.20% | -1609.93% | -780.36% |
Free Cash Flow Margin | -549.00% | -322.68% | -285.40% | -153.50% | -127.67% |
EBITDA | -79.75 | -82.02 | -115.1 | -134.39 | -136.74 |
EBITDA Margin | - | -205.94% | -157.20% | -160.74% | -168.40% |
D&A For EBITDA | 10.5 | 18.11 | 16.56 | 10.8 | 6.1 |
EBIT | -90.25 | -100.13 | -131.66 | -145.19 | -142.84 |
EBIT Margin | - | -251.43% | -179.81% | -173.66% | -175.91% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.